DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Northcoast Research decreased their Q3 2018 earnings per share estimates for DENTSPLY SIRONA in a report released on Wednesday. Northcoast Research analyst E. Snyder now forecasts that the medical instruments supplier will post earnings per share of $0.77 for the quarter, down from their previous estimate of $0.79.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Friday, November 3rd. The medical instruments supplier reported $0.70 EPS for the quarter, topping the Zacks’ consensus estimate of $0.66 by $0.04. The business had revenue of $1.01 billion for the quarter, compared to analyst estimates of $978.99 million. DENTSPLY SIRONA had a positive return on equity of 7.56% and a negative net margin of 20.33%. DENTSPLY SIRONA’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period last year, the company posted $0.66 earnings per share.

A number of other analysts have also commented on the company. HC Wainwright lowered DENTSPLY SIRONA from a “buy” rating to a “neutral” rating and set a $68.00 price target on the stock. in a report on Thursday. Stephens initiated coverage on DENTSPLY SIRONA in a research note on Tuesday. They issued an “overweight” rating and a $75.00 target price on the stock. TheStreet upgraded DENTSPLY SIRONA from a “c” rating to a “b-” rating in a research note on Friday, November 3rd. Stifel Nicolaus boosted their target price on DENTSPLY SIRONA from $66.00 to $70.00 and gave the company a “buy” rating in a research note on Monday, November 6th. Finally, Barrington Research upgraded DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $73.00 target price on the stock in a research note on Monday, November 6th. Three equities research analysts have rated the stock with a sell rating, three have given a hold rating and seven have assigned a buy rating to the stock. DENTSPLY SIRONA has an average rating of “Hold” and an average price target of $67.73.

Shares of DENTSPLY SIRONA (NASDAQ:XRAY) opened at $66.08 on Friday. The company has a market capitalization of $15,391.05, a price-to-earnings ratio of 26.70, a P/E/G ratio of 2.65 and a beta of 1.31. DENTSPLY SIRONA has a fifty-two week low of $52.53 and a fifty-two week high of $68.98. The company has a current ratio of 2.32, a quick ratio of 1.59 and a debt-to-equity ratio of 0.21.

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Alps Advisors Inc. grew its position in shares of DENTSPLY SIRONA by 0.3% in the second quarter. Alps Advisors Inc. now owns 7,523 shares of the medical instruments supplier’s stock valued at $488,000 after purchasing an additional 20 shares in the last quarter. Wetherby Asset Management Inc. grew its position in shares of DENTSPLY SIRONA by 0.6% in the second quarter. Wetherby Asset Management Inc. now owns 5,004 shares of the medical instruments supplier’s stock valued at $324,000 after purchasing an additional 30 shares in the last quarter. BRYN MAWR TRUST Co grew its position in shares of DENTSPLY SIRONA by 0.5% in the second quarter. BRYN MAWR TRUST Co now owns 12,064 shares of the medical instruments supplier’s stock valued at $782,000 after purchasing an additional 65 shares in the last quarter. Nordea Investment Management AB grew its position in shares of DENTSPLY SIRONA by 0.7% in the second quarter. Nordea Investment Management AB now owns 10,235 shares of the medical instruments supplier’s stock valued at $664,000 after purchasing an additional 75 shares in the last quarter. Finally, Security National Bank of Sioux City Iowa IA grew its position in shares of DENTSPLY SIRONA by 0.4% in the second quarter. Security National Bank of Sioux City Iowa IA now owns 23,081 shares of the medical instruments supplier’s stock valued at $1,497,000 after purchasing an additional 102 shares in the last quarter. Institutional investors own 96.59% of the company’s stock.

In other news, Director Francis J. Lunger sold 8,900 shares of DENTSPLY SIRONA stock in a transaction on Monday, November 13th. The stock was sold at an average price of $65.90, for a total value of $586,510.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Mark Thierer purchased 77,000 shares of DENTSPLY SIRONA stock in a transaction dated Monday, November 13th. The stock was bought at an average price of $66.04 per share, with a total value of $5,085,080.00. The disclosure for this purchase can be found here. Insiders own 1.99% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This story was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another website, it was copied illegally and reposted in violation of United States & international trademark and copyright legislation. The original version of this story can be accessed at https://www.thecerbatgem.com/2017/12/02/brokers-offer-predictions-for-dentsply-sirona-inc-s-q3-2018-earnings-xray.html.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Stock Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related stocks with our FREE daily email newsletter.